90
Participants
Start Date
June 2, 2021
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2026
methylprednisolone
The patients were treated with three protocols: (1) oral methylprednisolone, 40 mg for 3 days, 20 mg for 3 days, and 8 mg for 6 days; (2) oral methylprednisolone, 20 mg for 3 days, 10 mg for 3 days, and 4 mg for 6 days. At the same time, all patients received olfactory training for 12 weeks as proposed by Hummel et al
budesonide atomization suspension
(3) budesonide atomization suspension (AstraZeneca Trading Co., Ltd, AU.) inhaled through the nose atomized with an air compression atomizer for 4 weeks, 2 mg for the first 2 weeks and reduced to 1 mg for the last 2 weeks. At the same time, all patients received olfactory training for 12 weeks as proposed by Hummel et al
Department of Otolaryngology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER